Literature DB >> 3484473

Immunohistochemical study of the local inflammatory response to chlamydial ocular infection.

J A Whittum-Hudson, H R Taylor, M Farazdaghi, R A Prendergast.   

Abstract

Immunohistochemical staining of conjunctival biopsies from cynomolgus monkeys (Macaca fascicularis) was performed after they received a single primary ocular infection, a single secondary challenge infection, or repeated ocular inoculations with Chlamydia trachomatis. T cells of the suppressor/cytotoxic (OKT8F) phenotype predominated regardless of the infection protocol, and perifollicular T lymphocytes of both the suppressor/cytotoxic and helper (OKT4A) phenotypes appeared in large numbers during the peak inflammatory reaction. In repeatedly inoculated monkeys, T cells and follicles persisted until cessation of reinfection. IgM-bearing B lymphocytes comprised the majority of cells within follicles, with smaller numbers of IgG- or IgA-positive B cells. The major difference in the response to the various infection protocols was the increased number and persistence of follicles with repeated reinoculation. The finding of large numbers of T-suppressor/cytotoxic and T-helper cells in the infected conjunctiva supports a role for cell-mediated immunity in the local response to C. trachomatis ocular infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484473

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  Characterization of lymphocyte response in the female genital tract during ascending Chlamydial genital infection in the guinea pig model.

Authors:  R G Rank; A K Bowlin; K A Kelly
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Chlamydial heat shock proteins and trachoma.

Authors:  H R Taylor; I W Maclean; R C Brunham; S Pal; J Whittum-Hudson
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection.

Authors:  J A Whittum-Hudson; H R Taylor
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

4.  Conjunctival lymphocyte subsets in trachoma.

Authors:  E M Burd; K F Tabbara; A M Nasr; P B Taylor
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

5.  Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection.

Authors:  Ashlesh K Murthy; Weidang Li; Bharat K R Chaganty; Sangamithra Kamalakaran; M Neal Guentzel; J Seshu; Thomas G Forsthuber; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

6.  Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma.

Authors:  Troy Skwor; Ram Prasad Kandel; Sunniya Basravi; Aslam Khan; Bassant Sharma; Deborah Dean
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-12       Impact factor: 4.799

7.  Frequency of antigen-specific B cells during experimental ocular Chlamydia trachomatis infection.

Authors:  S Pal; H R Taylor; R B Huneke; R A Prendergast; J A Whittum-Hudson
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

8.  Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro.

Authors:  W L Beatty; G I Byrne; R P Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Cytotoxic and immunoregulatory function of intestinal lymphocytes in Chlamydia trachomatis proctitis of nonhuman primates.

Authors:  S P James; A S Graeff; M Zeitz; E Kappus; T C Quinn
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

Review 10.  [Classification of ocular surface disease. Part 1].

Authors:  F E Kruse; C Cursiefen; B Seitz; H E Völcker; G O H Naumann; L Holbach
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.